insights_auto
Why is CYAD down 6,36%?
Dive Deeperchevron_right
CYAD:EBR
Celyad Oncology SA
€0,21
arrow_downward
-6,36%(-0,014) 1D
14 Okt., 16:05:09 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CYAD...
Open
€0,22
High
€0,22
Low
€0,21
Mkt. cap
11,01 m
Avg. vol.
10,64 k
Volume
4,36 k
P/E ratio
2,74
52-wk high
€0,65
52-wk low
€0,16
EPS
€0,08
Shares outstanding
47,26 m
No. of employees
5
Open
€0,22
High
€0,22
Low
€0,21
Mkt. cap
11,01 m
Avg. vol.
10,64 k
Volume
4,36 k
P/E ratio
2,74
52-wk high
€0,65
52-wk low
€0,16
EPS
€0,08
Shares outstanding
47,26 m
No. of employees
5
News stories
From web sources and news partners
The Globe and Mail
·
1 uur gelede
The S&P 500 Has Risen 30.6% in the First 20 Months of Trump's Second Term, Just Ahead of the 28.5% Gain Over the Same Stretch of His First Term. Here's Why That Comparison Matters for Investors Heading Into the Midterms.
MarketBeat
·
1 uur gelede
CoreWeave (NASDAQ:CRWV) CRO Jonathan Jones Sells 15,811 Shares of Stock
NewsCord
·
1 uur gelede
US Stocks Slide After Inflation Accelerates to 3.7%, Nasdaq Drops 1.9%: 11 outlets compared
Bloomberg.com
·
5 uur gelede
S&P 500 Ends Longest Streak of Calm Since 2020 as AI Trade Sinks
About Celyad Oncology SA
CEOFilippo Petti
Employees5
Founded2004
HeadquartersMont-Saint-Guibert, Waals-Brabant, België
Sector-
Websitecelyad.com